Abstracts Archive - Page 1699 of 2607 - ACR Meeting Abstracts

Abstract Number: 1497 • 2016 ACR/ARHP Annual Meeting
Progressive Decline of Lung Function in Rheumatoid Arthritis Associated Interstitial Lung Disease
Alex Zamora-Legoff¹, Megan Krause², Cynthia S. Crowson³, Jay H. Ryu⁴ and Eric L. Matteson², ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic, Rochester, MN, ³Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
Background/Purpose: Interstitial lung disease (ILD) is associated with substantial morbidity in rheumatoid arthritis (RA), but virtually nothing is known about the long-term of progression of…
Abstract Number: 1498 • 2016 ACR/ARHP Annual Meeting
Patterns of Interstitial Lung Disease and Associated Mortality in Rheumatoid Arthritis
Alex Zamora-Legoff¹, Cynthia S. Crowson², Megan Krause³, Jay H. Ryu⁴ and Eric L. Matteson³, ¹Division of Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN, ⁴Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
Background/Purpose: To characterize a cohort of patients with rheumatoid arthritis (RA) who have interstitial lung disease (ILD) and to assess the utility of the GAP…
Abstract Number: 1499 • 2016 ACR/ARHP Annual Meeting
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
Masaomi Yamasaki, Rheumatology, Shin-Yokohama Arthritis and Rheumatology Clinic, Yokohama, Japan
Background/Purpose: Serum anti-cyclic citrullinated peptide antibodies (anti-CCP2) positivity was associated with presence of interstitial lung disease and airway disease in rheumatoid arthritis (RA). This study…
Abstract Number: 1500 • 2016 ACR/ARHP Annual Meeting
Concomitant Development of Interstitial Pneumonia Associated with Dermatomyositis and Rheumatoid Arthritis
Takeshi Shoda^1,2, Tohru Takeuchi³, Kentaro Isoda⁴, Takao Kiboshi⁴ and Shigeki Makino³, ¹Division of Clinical Immunology and Rheumatology, Osaka medical college, Osaka, Japan, ²Department of Rheumatology, Yodogawa Christian Hospital, Osaka, Japan, ³Osaka medical college, Osaka, Japan, ⁴Yodogawa Christian Hospital, Osaka, Japan
Background/Purpose: A few cases of the concomitant development of interstitial pneumonia associated with dermatomyositis (DM-IP) and rheumatoid arthritis (RA) have been reported mainly in Asia,…
Abstract Number: 1501 • 2016 ACR/ARHP Annual Meeting
The Incidence of Interstial Lung Disease and Malignancies in Veterans with Rheumatoid Arthritis
Katherine Larson¹, Faizah Siddique² and Samya Mohammad¹, ¹Virginia Commonwealth University, Richmond, VA, ²Department of Veterans Affairs, Richmond, VA
Background/Purpose: Rheumatoid arthritis (RA) is a systemic disease with a known association with lymphoma and interstitial lung disease (ILD). ILD is a frequent extraarticular manifestation…
Abstract Number: 1502 • 2016 ACR/ARHP Annual Meeting
Vaccination Program to Prevent Hospital Admissions Due to Serious Respiratory Infections in Rheumatoid Arthritis Patients. Prosprective Study of 294 Patients
Lucia C. Domínguez-Casas¹, Paz Rodríguez-Cundín², Vanesa Calvo-Río¹, Ricardo Blanco¹, Nuria Vegas-Revenga³, Carlos Fernández Díaz¹, Virginia Portilla³, FM Antolin², MH Rebollo-Rodrigo², Alfonso Corrales¹, Natalia Palmou-Fontana¹ and Miguel Angel Gonzalez-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ²Preventive Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain
Background/Purpose: Patients with Rheumatoid Arthritis (RA) are at increased risk of infections, especially serious respiratory infections. Immunization is a recommended to reduce these complications.…
Abstract Number: 1503 • 2016 ACR/ARHP Annual Meeting
Patterns and Factors Associated with Immunization Among Adult Patients with Rheumatic Diseases in the US
Huifeng Yun¹, Shuo Yang², Sofia Pedro³, Jeffrey Curtis⁴ and Kaleb Michaud⁵, ¹Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, ²Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³National Data Bank for Rheumatic Diseases, Wichita, KS, ⁴Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Rates of adult vaccination are low in patients with autoimmune disease despite broad recommendations for many years. In the U.S., pneumococcal vaccination is recommended…
Abstract Number: 1504 • 2016 ACR/ARHP Annual Meeting
Fluoroquinolone Resistance in Escherichia coli Urinary Tract Infections Among Patients with Rheumatoid Arthritis: Does Use of Hydroxichloroquine Matter?
Karen Ferez-Blando¹, Hilda Fragoso-Loyo², Alfredo Ponce de León³, Sergio Ponce de Leon-Rosales⁴ and Yemil Atisha-Fregoso¹, ¹Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³Department of Infectology and Microbiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ⁴Direccion de Enseñanza, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease that requires chronic immunosuppressive treatment. Urinary tract infections (UTI) are common among patients with RA. It…
Abstract Number: 1505 • 2016 ACR/ARHP Annual Meeting
Trends in Hospitalizations for Infections in US Patients with Rheumatoid Arthritis, 1993-2013
Sadao Jinno¹, Na Lu^2,3, S. Reza Jafarzadeh⁴ and Maureen Dubreuil^3,5, ¹Rheumatology, Boston University School of Medicine, Boston, MA, ²Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Clinical Epidemiology, Boston University School of Medicine, Boston, MA, ⁴Medicine, Washington University School of Medicine, St Louis, MO, ⁵Rheumatology, Boston VA HealthCare System, Boston, MA
Background/Purpose: With the increasing uptake of RA treatments that confer infection risk, an increase in the rates of infection hospitalizations among RA patients is expected,…
Abstract Number: 1506 • 2016 ACR/ARHP Annual Meeting
One Third of Patients with Established Rheumatoid Arthritis (RA) Are Correctly Vaccinated Against Influenza and Pneumococcus and This Is Increasing: 3 Year Longitudinal Assessment of 776 Patients
Laure Gossec¹, Martin Soubrier², Frantz Foissac³, Anna Molto⁴, Thomas Bardin⁵, Francis Berenbaum⁶, Alain Cantagrel⁷, Marie Hélène Cerato⁸, Gerard H. Chales⁹, Isabelle Chary-Valckenaere¹⁰, Bernard Combe¹¹, Emmanuelle Dernis Labous¹², Liana Euller-Ziegler¹³, Rene-Marc Flipo¹⁴, Philippe Gaudin¹⁵, Melanie Gilson¹⁶, Sandrine Guis¹⁷, Xavier Mariette¹⁸, Gaël Mouterde¹⁹, Sophie Pouplin²⁰, Pascal Richette²¹, Alain Saraux²², Thierry Schaeverbeke²³, Jean Sibilia²⁴, Françoise Fayet²⁵ and Maxime Dougados²⁶, ¹Rheumatology, Pitié Salpêtrière Hospital, Paris, France, ²Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, ³COMEDRA working group, Paris, France, ⁴Hopital Cochin, Paris Descartes University, Paris, France, ⁵Hôpital Lariboisière, Paris, France, ⁶Rheumatology dept, APHP St-Antoine hospital, Univ Paris 06, Paris, France, Paris, France, ⁷Purpan Hospital, Toulouse, France, ⁸University Hospital, Toulouse, France, ⁹CHU RENNES, Rennes, France, ¹⁰University Hospital, Nancy, France, ¹¹Lapeyronie Hospital, Montpellier, France, ¹²Le Mans Hospital, Le Mans, France, ¹³Rheumatology, Nice, France, ¹⁴Rheumatology, University Hospital, Lille, France, ¹⁵Rheumatology, Grenoble University Hospital, France, Grenoble, France, ¹⁶Hopital Sud, Grenoble, France, ¹⁷Rheumatology 1, CRMBM-CEMEREM 7339, Aix-Marseille Université, AP-HM, CNRS, Marseilles, France, ¹⁸Rheumatology, Rheumatology department, Bicetre Hospital, Paris-Sud University, Le Kremlin Bicetre, France, ¹⁹Rheumatology Department, Hopital Lapeyronie, Montpellier, France, ²⁰Rheumatology Department & Inserm 905, Department of Rheumatology, Rouen University Hospital & Inserm 905, Institute for Biomedical Research, University of Rouen, Rouen, France, ²¹Rhumatologie, Hôpital Lariboisière, Paris, France, ²²Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, ²³Rheumatology, CHU Bordeaux, Bordeaux, France, ²⁴Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France, ²⁵Rheumatology, CHU Gabriel-Montpied, Clermont-Ferrand, France, ²⁶Cochin Hospital and Paris 05 University, Paris, France
Background/Purpose: Influenza and pneumococcal vaccinations are recommended in all patients with RA. However, it is well known that a gap exists between recommendations and their…
Abstract Number: 1507 • 2016 ACR/ARHP Annual Meeting
Our Strategy of Preventing Tuberculosis (TB) in Patients with Rheumatic Diseases Under the Treatment with Biologic Dmards
Shinji Motojima¹, Tamao Nakashita², Akira Jibatake¹, Akira Yoshida¹ and Yoshiki Yamamoto¹, ¹Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa city, Japan, ²Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa-city, Japan
Background/Purpose: According to the report by WHO, Japan is still in moderately-prevailing countries of TB. The annual incidence of TB in Japan is approximately 15/100,000,…
Abstract Number: 1508 • 2016 ACR/ARHP Annual Meeting
Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients: A Cross-Sectional Analysis
David J. Ozeri¹, Joshy Pathiparampil², Randolph Sanchez² and Isabel M. McFarlane³, ¹Rheumatology, SUNY Downstate Medical Center, brooklyn, NY, ²Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY, ³Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY
Title: Prevalence and Clinical Characteristics of Rheumatoid Arthritis in Sickle Cell Patients Background/Purpose: Rheumatoid arthritis (RA) has been rarely reported in association with sickle cell…
Abstract Number: 1509 • 2016 ACR/ARHP Annual Meeting
Increased Fracture Risk in Patients with Early Rheumatoid Arthritis in the 1990s As Well As in the 2000s: A Prospective General Population-Matched Cohort Study
Britt-Marie Nyhäll-Wåhlin¹, Sofia Ajeganova², Ingemar F Petersson³ and Maria LE Andersson⁴, ¹Department of Rheumatology, Falun Hospital, Falun, Sweden, ²Rheumatology unit, Department of Medicine,, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden, ³Lund University, Department of Orthopedics, Clinical Sciences Lund, Lund, Sweden, ⁴R&D Centre Spenshult, Halmstad, Halmstad, Sweden
Background/Purpose: Osteoporotic fractures represent one of the serious extra-articular manifestations of rheumatoid arthritis (RA). The aim of this study was to investigate whether fracture incidence…
Abstract Number: 1510 • 2016 ACR/ARHP Annual Meeting
Trends in the Occurrence of Malignancy in Japanese Patients with Rheumatoid Arthritis Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort during a 14-Year Observation Period
Naoki Sugimoto, Eiichi Tanaka, Eisuke Inoue, Moeko Ochiai, Yoko Shimizu, Rei Yamaguchi, Kumi Shidara, Ayako Nakajima, Atsuo Taniguchi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: Along with increased proportions of patients using methotrexate (MTX) and biological agents (from 34.2% and 0.0% in 2000 to 77.3% and 18.8% in 2013,…
Abstract Number: 1511 • 2016 ACR/ARHP Annual Meeting
Impacts of Disease Activity and Serum Level of Neurotrophic Factors on Depression in Rheumatoid Arthritis
Young Sun Suh¹, Yun-Hong Cheon², Hyun-Ok Kim¹, Hye Song Lim³, Hae Sook Noh³, Sang-Hyon Kim⁴, Ji-Min Kim⁴, Chang-Nam Son⁴, Seung-Geun Lee⁵, Eun-Kyoung Park⁵ and Sang-Il Lee³, ¹Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea, The Republic of, ²Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea, The Republic of, ³Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea, The Republic of, ⁴Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea, The Republic of, ⁵Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea, The Republic of
Background/Purpose: Rheumatoid arthritis (RA) and depression is closely associated with each other. The serum level of neurotrophic factors are related with the major depressive disorder…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].